- Targeted stakeholdersMay increase public awareness of triple-negative breast cancer, potentially encouraging earlier detection and treatment.
- Targeted stakeholdersCould focus researchers and fundraisers on triple-negative breast cancer priorities and philanthropic giving.
- Targeted stakeholdersHighlights racial and genetic disparities, potentially prompting equity-focused screening and outreach programs.
Expressing support for the designation of March 3, 2026, as "National Triple-Negative Breast Cancer Day".
Referred to the House Committee on Oversight and Government Reform.
This House resolution expresses support for designating March 3, 2026, as "National Triple-Negative Breast Cancer Day." It cites facts about triple-negative breast cancer (TNBC): its 2006 recognition, prevalence (10–15% of cases), higher mortality share (~25% of breast cancer deaths), and disproportionate impact on young, Black, Hispanic, and BRCA‑mutation patients.
The measure is a nonbinding expression of support to raise awareness and encourage action to eradicate TNBC.
As a House simple resolution expressing support, it is nonbinding and cannot become statute; adoption would be symbolic only.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly states the problem context and unambiguously designates March 3, 2026, as National Triple-Negative Breast Cancer Day.
Liberals want linked funding and equity measures; conservatives want symbolism only
Who stands to gain, and who may push back.
- Targeted stakeholdersIs purely symbolic and contains no funding, so it may not change clinical outcomes.
- Targeted stakeholdersMay divert limited attention and resources from other cancers or public health priorities.
- Targeted stakeholdersCreates no statutory programs or authority, limiting enforceability and programmatic impact.
Why the argument around this bill splits.
Liberals want linked funding and equity measures; conservatives want symbolism only
Likely strongly supportive because the resolution highlights health disparities and a severe, understudied cancer subtype.
They will view awareness designation as a useful step but insufficient without commitments to equity, research funding, and access to care.
Generally favorable because it's nonbinding, low‑cost symbolism raising awareness of a specific health problem.
They will want clarity on follow‑up actions, measurable goals, and avoidance of unfunded mandates.
Likely supportive in principle because it is a symbolic, humanitarian recognition of a serious disease.
They will be wary of any downstream calls for federal spending or regulatory action tied to the designation.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a House simple resolution expressing support, it is nonbinding and cannot become statute; adoption would be symbolic only.
- Whether the House will prioritize floor consideration
- Whether a companion or concurrent Senate resolution will be introduced
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals want linked funding and equity measures; conservatives want symbolism only
As a House simple resolution expressing support, it is nonbinding and cannot become statute; adoption would be symbolic only.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly states the problem context and unambiguously designates March 3, 2026, as National Triple-Negative Breast C…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.